Stem Cell Theranostics
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
AngelList URL
B2X
CEO
Company Operating Status
Active
Strategic Partnerships
Country
Crunchbase URL
Date Incorporated
2013
DUNS Number
968406186
Email Address
rachel.bolger@sctheranostics.com
Facebook URL
Founded Date
2013
Founder
Glassdoor ID
Headquarters
Investors
Latest Funding Type
LinkedIn URL
Phone Number
+12129205501
Pitchbook URL
Total Funding Amount (USD)
5,500,000
Official Website
Wellfound ID
Wikidata ID
Find more companies like Stem Cell Theranostics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
